๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA ยท Real-Time Price ยท USD
42.23
-0.39 (-0.92%)
At close: Nov 18, 2026, 4:00 PM EST
42.21
-0.02 (-0.05%)
After-hours: Nov 18, 2026, 4:52 PM EST

Teva Pharmaceutical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
17,23017,25816,54415,84614,92515,878
Revenue Growth
2.71%4.32%4.41%6.17%-6.00%-4.69%
Gross Profit
9,2208,9388,0637,6466,9737,594
Operating Income
3,4203,9523,3733,1852,6623,079
Net Income
5061,410-1,639-559-2,446417
Earnings Per Share
0.431.21-1.45-0.50-2.200.38
EPS Growth
-30.83%-----

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue from Sale of Goods
14,39914,60514,05012,97912,76613,829
Licensing Arrangements
675678173681212160
Distribution
1,6341,5511,5761,6151,5191,390
Other Segment
520423745570428500
Revenue (Total)
17,23017,25816,54415,84614,92515,878

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4,0853,5563,3003,2262,8012,165
Total Debt
16,99817,23018,18420,27321,67623,593
Net Cash (Debt)
-12,913-13,674-14,884-17,047-18,875-21,428
Net Cash Growth
------
Net Cash Per Share
-10.96-11.76-13.16-15.23-17.00-19.36

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,7701,6491,2471,3681,590798
Capital Expenditures
-535-501-498-526-548-562
Free Cash Flow
1,2351,1487498421,042236
Free Cash Flow Growth
113.67%53.27%-11.04%-19.19%341.52%-63.01%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
53.51%51.79%48.74%48.25%46.72%47.83%
Operating Margin
19.85%22.90%20.39%20.10%17.84%19.39%
Pretax Margin
2.15%7.17%-7.76%-3.93%-21.05%4.20%
Profit Margin
2.94%8.17%-9.91%-3.53%-16.39%2.63%
FCF Margin
7.17%6.65%4.53%5.31%6.98%1.49%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
98.9323.28---22.88
P/FCF Ratio
39.8628.5928.0211.489.5340.43
PS Ratio
2.861.901.270.610.670.60